icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025
 		Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Lenacapavir, Teropavimab, and Zinlirvimab: Phase 2 Week 26 Primary Outcome
 
 
  CROI 2025 SF March 9-12

0312251

0312252

0312253

0312254

0312255

0312256

0312257

0312258

0312259